(C) Immunoprecipitation of the endogenous Squ from ovarian lysate revealed the interaction with Spn-E protein. Proteins were detected by western blotting analysis using the specific antibody for each ...

Thermo Fisher's Q3 numbers just dropped, and while revenue hit $10.60 billion (a slight uptick from Q2), it's flat compared ...

The global gene editing market is expected to reach USD 7.59 billion in 2029 from USD 4.66 billion in 2024, at a CAGR of 10.2 ...

WALTHAM, Mass., November 15, 2024--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized the ...

What Is the Projected Market Size of the Global Electronics And Appliance Stores Market and Its Growth Rate? The electronics and appliance stores market is projected to experience solid growth over ...

Adaptimmune’s Phase II IGNYTE-ESO trial investigating experimental T cell therapy lete-cel has achieved its primary endpoint.

Thermo Fisher Scientific has good revenue and margin growth prospects ahead and is trading at a discount. See why TMO stock ...

Thermo Fisher Scientific Inc. is one of the leading providers of medical equipment, analytical instruments, reagents & consumables, software, and services. Through its Life Science Solutions segment, ...

The Cas nuclease market is on an upward trajectory, forecasted to grow from $2.75 billion in 2023 to $3.27 billion in 2024, at a CAGR of 18.9%. Key drivers include the rapid advancements in genome ...

Key Players: Prominent market players include Bio-Rad Laboratories, Chembio Diagnostics, Enfer, IDEXX Laboratories, IDVet, LIONEX, PBD Biotech, QIAGEN, Thermo Fisher Scientific, and ZENDAL. These ...

McDonald’s Corp. is selling its first Swiss franc-denominated bond since 2016 in a deal that will test investor demand in the ...